During the course of the Presidential campaign, Obama signaled his intention to reverse Bush’s controversial limit on federal funding of embryonic stem cell research.
ACAAI 2008: Immunotherapy Reduces New Allergies in Young Children With Allergic Rhinitis
Published in November 11th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
A retrospective analysis showed that subcutaneous immunotherapy reduced the number of new sensitizations in children younger than 6 years with allergic rhinitis.
Medscape Medical News
ACAAI 2008: Ecallantide Effective for Hereditary Angioedema
Published in November 11th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
In a phase 3 trial, ecallantide, the recombinant peptide plasma kallikrein inhibitor DX-88, reduces the severity of acute hereditary angioedema attacks.
Medscape Medical News
Raptor Pharmaceuticals announces positive results for Convivia program
Published in November 11th, 2008
Comments Off
Raptor Pharmaceuticals Corp. has announced positive results in its Phase IIa study of oral 4-methylpyrazole (”4-MP”) in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
Rivaroxaban shows promise in patients with acute coronary syndrome
Published in November 11th, 2008
Comments Off
Researchers reported on a study of a new oral anti-clotting agent - rivaroxaban - designed to identify doses that would be safe to test in subsequent Phase III efficacy and safety trials. The results of ATLAS ACS-TIMI 46 were presented as a late-breaking clinical trial at the American Heart Association’s Scientific Sessions 2008.
Exercise training safe in heart failure patients - offer clinical benefit
Published in November 11th, 2008
Comments Off
Exercise training is safe in heart failure patients, does not significantly reduce hospitalization or death, but is associated with several improved clinical outcomes, even in those already receiving optimal medical care, researchers reported at the American Heart Association’s Scientific Sessions 2008. The Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) was presented as a late-breaking clinical trial.
Interferon eliminates specific causes of some viruses in heart failure patients, improving clinical outcomes
Published in November 11th, 2008
Comments Off
Giving interferon to heart failure patients with evidence of a chronic viral infection safely eliminated two viruses from their systems and reduced levels of a third virus.
Testosterone Patch May Increase Low Libido in Postmenopausal Women
Published in November 11th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
In a phase 3 trial, postmenopausal women who were not receiving estrogen therapy had modest success using a testosterone patch to increase low libido.
Medscape Medical News
AAO/SOE 2008: Ranibizumab Appears Safe for Wet Age-Related Macular Degeneration
Published in November 11th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Ranibizumab appears safe in the treatment of wet age-related macular degeneration, according to an analysis of 4 large phase 3 trials.
Medscape Medical News
AHA 2008: JPAD: No Effect of Aspirin Primary-CV-Event Prevention in Diabetics
Published in November 11th, 2008
Posted by Medscape Pharmacists Headlines in Drugs and Food Information, Health Information, Pharmaceutical Industry News
Comments Off
Low-dose aspirin did not reduce risk for cardiovascular events but may have reduced cardiovascular mortality, a secondary end point, in the randomized but open-label trial conducted in Japan.
Medscape Medical News